Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Losartan as Anti-inflammatory Therapy to Augment F508del Cystic Fibrosis Transmembrane (CFTR) Recovery

NCT03206788 is registered in ClinicalTrials.gov with University of Miami as lead sponsor.

NCT NCT03206788
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03206788 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Losartan as Anti-inflammatory Therapy to Augment F508del Cystic Fibrosis Transmembrane (CFTR) Recovery
Lead sponsor
University of Miami
Phase
Phase 2
Overall status
Terminated
Start date
November 11, 2017
Completion date
December 30, 2019
Enrollment
7 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis